Literature DB >> 17623472

HPLC analysis and pharmacokinetics of icariin in rats.

Shan Cheng1, Feng Qiu, Shuhui Wang, Junqi He.   

Abstract

As a prerequisite to the determination of pharmacokinetic parameters of icariin in rats, an HPLC method using UV detection was developed and validated. Icariin and the internal standard, quercetin, were extracted from plasma samples using ethyl acetate after acidification with 0.05 mol/L NaH2PO4 solution (pH 5.0). Chromatographic separation was achieved on an Agilent XDB Cls column (250 x 4.6 mm id, 5 microm) equipped with a Shim-pack GVP-ODS C18 guard column (10 x 4.6 mm id, 5 microm) using a mobile phase of ACN/water/acetic acid (31:69:0.4 v/v/v) at a flow rate of 1.0 mL/ min. Detection was at 277 nm. The calibration curve was linear from 0.05 to 100.0 microg/mL with 0.05 microg/mL as the lower LOQ (LLOQ) in plasma. The intra- and interday precisions in terms of RSD were lower than 5.7 and 7.8% in rat plasma, respectively. The accuracy in terms of relative error (RE) ranged from -1.6 to 3.2%. The extraction recoveries of icariin and quercetin were 87.6 and 80.1%, respectively. The main pharmacokinetic parameters for rats were determined after a single intravenous administration of 10 mg/kg icariin: t1/2, 0.562 +/- 0.200 h; AUC0-infinity, 8.73 +/- 2.23 microg x h/mL; CLToT, 20.10 +/- 5.80 L/kg x h; Vz, 1.037 +/- 0.631 L/kg; MRT0-infinity, 0.134 +/- 0.040 h; and Vss, 0.170 +/- 0.097 L/kg.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17623472     DOI: 10.1002/jssc.200600313

Source DB:  PubMed          Journal:  J Sep Sci        ISSN: 1615-9306            Impact factor:   3.645


  6 in total

1.  Determination of small molecule ABAD inhibitors crossing blood-brain barrier and pharmacokinetics.

Authors:  Jhansi Rani Vangavaragu; Koteswara Rao Valasani; Du Fang; Todd D Williams; Shirley ShiDu Yan
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

2.  Effects of icariin on orthodontic tooth movement in rats.

Authors:  Yun Chen; Xu-Xia Wang; Bing-Jie Zhao; Jie Bu; Yu-Ran Su; Jun Zhang
Journal:  Int J Clin Exp Med       Date:  2015-06-15

3.  Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.

Authors:  Ye Zhang; Qiang-Song Wang; Yuan-Lu Cui; Fan-Cui Meng; Ke-Ming Lin
Journal:  Int J Nanomedicine       Date:  2012-08-02

4.  Comparative study of two types of herbal capsules with different Epimedium species for the prevention of ovariectomised-induced osteoporosis in rats.

Authors:  Shi-Hui Chen; Xin-Luan Wang; Li-Zhen Zheng; Yi Dai; Jia-Yong Zhang; Bao-Lin Guo; Zhi-Jun Yang; Xin-Sheng Yao; Ling Qin
Journal:  J Orthop Translat       Date:  2015-08-29       Impact factor: 5.191

5.  Compound of icariin, astragalus, and puerarin mitigates iron overload in the cerebral cortex of Alzheimer's disease mice.

Authors:  Yu Zhang; Wei-Na Kong; Xi-Qing Chai
Journal:  Neural Regen Res       Date:  2018-04       Impact factor: 5.135

6.  Development of an Icariin-Loaded Bilosome-Melittin Formulation with Improved Anticancer Activity against Cancerous Pancreatic Cells.

Authors:  Nabil A Alhakamy; Shaimaa M Badr-Eldin; Waleed S Alharbi; Mohamed A Alfaleh; Omar D Al-Hejaili; Hibah M Aldawsari; Basma G Eid; Rana Bakhaidar; Filippo Drago; Filippo Caraci; Giuseppe Caruso
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.